The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), the central, self-governing research funding organization in Germany, has notified Molecular Pharmacology that the above article by Henschler et al. (1991) contains falsified information. An interinstitutional task force organized by the DFG investigated falsification allegations against Prof. Friedhelm Herrmann and Marion Brach. Prof. Herrmann is the corresponding author of the above article. The task force determined that the above article was falsified. Molecular Pharmacology was officially notified of this in a letter from Dr. Reinhard Grunwald dated October 30, 2006.
The article was retracted on November 14, 2006.
Board of Publications Trustees
ASPET
- The American Society for Pharmacology and Experimental Therapeutics
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
- Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.
- Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2α (eIF2α)-kinase (PERK) and general control nonderepressible-2 eIF2α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503–515; DOI: https://doi.org/10.1124/mol.109.056002.
Similar Articles
Advertisement